Affiliation:
1. Department of Analytical and Structural Chemistry CSIR‐Indian Institute of Chemical Technology Hyderabad Telengana India
2. Academy of Scientific and Innovative Research (AcSIR) Ghaziabad India
Abstract
AbstractA systematic and novel quality by design–enabled, rapid, simple, and economic stability–indicating HPLC method for quantifying nirmatrelvir (NMT) was successfully developed and validated. An analytical target profile (ATP) was established, and critical analytical attributes (CAAs) were allocated to meet the ATP requirements. The method used chromatographic separation using a Purosphere column with a 4.6 mm inner diameter × 250 mm (2.5 μm). The analysis occurred at 50°C with a flow rate of 1.2 mL/min and detection at 220 nm. A 10 μL sample was injected, and the mobile phase consisted of two components: mobile phase A, containing 0.1% formic acid in water (20%), and mobile phase B, containing 0.1% formic acid in acetonitrile (80%). The diluent was prepared by mixing acetonitrile and water at a 90:10 v/v ratio. The retention time for the analyte was determined to be 2.78 min. Accuracy exceeded 99%, and the correlation coefficient was greater than 0.999. The validated HPLC method was characterized as precise, accurate, and robust. Significantly, NMT was found to be susceptible to alkaline, acidic, and peroxide conditions during forced degradation testing. The stability‐indicating method developed effectively separated the degradation products formed during stress testing, underlining its effectiveness in stability testing and offering accuracy, reliability, and sensitivity in determining NMT.
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry
Reference9 articles.
1. Green adherent degradation kinetics study of Nirmatrelvir, an oral anti-COVID-19: characterization of degradation products using LC–MS with insilico toxicity profile
2. Design Expert 13.0.0. Stat‐Ease Inc. Minneapolis. (2023).https://www.statease.com/software/design-expertFDA Updates on Paxlovid for Health Care Providers | FDA (accessed August 25 2023)
3. ICH International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Harmonized Tripartite Guideline Stability Testing of New Drug Substances and Products Q1A(R2). (2003) (accessed August 25 2023)
4. International Conference on Harmonization. (2005)ICH Q2 (R1): Validation of analytical procedures: Text and methodology. ICH Secretariat Geneva.
5. Label (fda.gov). (n.d.).https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217188s000lbl.pdf(accessed 25 August 2023)